scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...880712N |
P356 | DOI | 10.1371/JOURNAL.PONE.0080712 |
P932 | PMC publication ID | 3842918 |
P698 | PubMed publication ID | 24312238 |
P5875 | ResearchGate publication ID | 259208696 |
P50 | author | Yuki Tobisawa | Q43165986 |
P2093 | author name string | Kohta Kurohane | |
Yasuo Niwa | |||
Yasuyuki Imai | |||
Hirokazu Kobayashi | |||
Katsuhiro Nakanishi | |||
Shiori Ichikawa | |||
Sanshiro Narimatsu | |||
P2860 | cites work | Diarrheagenic Escherichia coli | Q24533466 |
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections | Q24550740 | ||
Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli | Q27644365 | ||
Food-related illness and death in the United States | Q29615940 | ||
Pathogenic Escherichia coli | Q29616738 | ||
KNOX homeobox genes are sufficient in maintaining cultured cells in an undifferentiated state in rice | Q33335899 | ||
Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis | Q33350981 | ||
The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome | Q33375970 | ||
Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). | Q33380757 | ||
Verotoxins induce apoptosis in human renal tubular epithelium derived cells | Q33502606 | ||
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo | Q33960542 | ||
Codon bias and heterologous protein expression | Q33979754 | ||
A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. | Q34029668 | ||
Antibody degradation in tobacco plants: a predominantly apoplastic process | Q34114675 | ||
Vero response to a cytotoxin of Escherichia coli | Q34177128 | ||
Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants | Q34240349 | ||
Increased risistance of immunoglobulin A dimers to proteolytic degradation after binding of secretory component | Q34509783 | ||
Monoclonal antibody manufacturing in transgenic plants--myths and realities | Q35026027 | ||
Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination | Q35865115 | ||
The function of immunoglobulin A in immunity | Q36346119 | ||
The intergenic region of Arabidopsis thaliana cab1 and cab2 divergent genes functions as a bidirectional promoter. | Q50605137 | ||
Production of biologically active human thioredoxin 1 protein in lettuce chloroplasts. | Q54369243 | ||
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. | Q54764104 | ||
Is the drought over for pharming? | Q55049745 | ||
Development of recombinant B subunit of Shiga-like toxin 1 as a probe to detect carbohydrate ligands in immunochemical and flowcytometric application | Q72996597 | ||
The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA | Q74844601 | ||
Lack of Shiga-like toxin binding sites in germinal centres of mouse lymphoid tissues | Q78032181 | ||
Transformation of Arabidopsis with plant-derived DNA sequences necessary for selecting transformants and driving an objective gene | Q83622211 | ||
Presence and survival of Escherichia coli O157:H7 on lettuce leaves and in soil treated with contaminated compost and irrigation water | Q83828573 | ||
Process economics of industrial monoclonal antibody manufacture | Q36561343 | ||
Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function | Q37182165 | ||
Production of antibodies in plants: status after twenty years | Q37687534 | ||
Advances in plant molecular farming | Q37813216 | ||
Establishment of recombinant hybrid-IgG/IgA immunoglobulin specific for Shiga toxin. | Q39480986 | ||
The C-terminal extension of a hybrid immunoglobulin A/G heavy chain is responsible for its Golgi-mediated sorting to the vacuole | Q39890815 | ||
Characterization of monoclonal immunoglobulin a and g against shiga toxin binding subunits produced by intranasal immunization | Q39941532 | ||
Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue | Q40403001 | ||
The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40. | Q40920782 | ||
Errors of heterologous protein expression | Q41238667 | ||
Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen. | Q41517521 | ||
Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors | Q41827248 | ||
Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis | Q42372450 | ||
Neutralizing antibodies against rotavirus produced in transgenically labelled purple tomatoes | Q44118745 | ||
Characterization of a shiga-toxin 1-resistant stock of vero cells | Q44950684 | ||
Increasing expression of P450 and P450-reductase proteins from monocots in heterologous systems | Q47850773 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e80712 | |
P577 | publication date | 2013-11-28 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1. | |
P478 | volume | 8 |
Q89552975 | A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs |
Q35241502 | Monomeric IgA can be produced in planta as efficient as IgG, yet receives different N-glycans |
Q90123302 | Plant-derived secretory component forms secretory IgA with shiga toxin 1-specific dimeric IgA produced by mouse cells and whole plants |
Q38709306 | Protection of Human Colon Cells from Shiga Toxin by Plant-based Recombinant Secretory IgA. |
Q43226570 | Shiga toxin-induced apoptosis is more efficiently inhibited by dimeric recombinant hybrid-IgG/IgA immunoglobulins than by the parental IgG monoclonal antibodies |
Search more.